169 related articles for article (PubMed ID: 21430300)
1. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.
Kwon EM; Salinas CA; Kolb S; Fu R; Feng Z; Stanford JL; Ostrander EA
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):923-33. PubMed ID: 21430300
[TBL] [Abstract][Full Text] [Related]
2. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Dossus L; Kaaks R; Canzian F; Albanes D; Berndt SI; Boeing H; Buring J; Chanock SJ; Clavel-Chapelon F; Feigelson HS; Gaziano JM; Giovannucci E; Gonzalez C; Haiman CA; Hallmans G; Hankinson SE; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kolonel LN; Kraft P; Ma J; Le Marchand L; Lund E; Peeters PH; Stampfer M; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D; Tumino R; Riboli E; Virtamo J; Weinstein SJ; Yeager M; Ziegler RG; Cox DG
Carcinogenesis; 2010 Mar; 31(3):455-61. PubMed ID: 19965896
[TBL] [Abstract][Full Text] [Related]
3. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
[TBL] [Abstract][Full Text] [Related]
4. Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.
Langeberg WJ; Tahir SA; Feng Z; Kwon EM; Ostrander EA; Thompson TC; Stanford JL
Prostate; 2010 Jun; 70(9):1020-35. PubMed ID: 20209490
[TBL] [Abstract][Full Text] [Related]
5. A pilot study on prostate cancer risk and pro-inflammatory genotypes: pathophysiology and therapeutic implications.
Balistreri CR; Caruso C; Carruba G; Miceli V; Campisi I; Listì F; Lio D; Colonna-Romano G; Candore G
Curr Pharm Des; 2010; 16(6):718-24. PubMed ID: 20388081
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
Mondul AM; Shui IM; Yu K; Travis RC; Stevens VL; Campa D; Schumacher FR; Ziegler RG; Bueno-de-Mesquita HB; Berndt S; Crawford ED; Gapstur SM; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Hunter DJ; Johansson M; Key TJ; Le Marchand L; Lindström S; McCullough ML; Navarro C; Overvad K; Palli D; Purdue M; Stampfer MJ; Weinstein SJ; Willett WC; Yeager M; Chanock SJ; Trichopoulos D; Kolonel LN; Kraft P; Albanes D
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):688-96. PubMed ID: 23377224
[TBL] [Abstract][Full Text] [Related]
7. Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk.
Kwon EM; Holt SK; Fu R; Kolb S; Williams G; Stanford JL; Ostrander EA
Cancer Epidemiol; 2012 Aug; 36(4):347-53. PubMed ID: 22542949
[TBL] [Abstract][Full Text] [Related]
8. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.
Langeberg WJ; Kwon EM; Koopmeiners JS; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):258-64. PubMed ID: 20056646
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control Study.
Ankathil R; Mustapha MA; Abdul Aziz AA; Mohd Shahpudin SN; Zakaria AD; Abu Hassan MR; Musa KI
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1621-1632. PubMed ID: 31244280
[TBL] [Abstract][Full Text] [Related]
10. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; De Marzo AM; Drake CG; Platz EA
Prostate; 2017 Jun; 77(8):908-919. PubMed ID: 28317149
[TBL] [Abstract][Full Text] [Related]
11. Interactive effect of TLR SNPs and exposure to sexually transmitted infections on prostate cancer risk in Jamaican men.
Dubey B; Jackson M; Zeigler-Johnson C; Devarajan K; Flores-Obando RE; McFarlane-Anderson N; Tulloch-Reid M; Aiken W; Kimbro K; Reed D; Kidd LR; Gibbs D; Kumar S; Ragin C
Prostate; 2020 Nov; 80(15):1365-1372. PubMed ID: 32894795
[TBL] [Abstract][Full Text] [Related]
12. Inflammation-related gene variants as risk factors for pancreatic cancer.
Reid-Lombardo KM; Fridley BL; Bamlet WR; Cunningham JM; Sarr MG; Petersen GM
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1251-4. PubMed ID: 21467233
[TBL] [Abstract][Full Text] [Related]
13. EphB2 SNPs and sporadic prostate cancer risk in African American men.
Robbins CM; Hooker S; Kittles RA; Carpten JD
PLoS One; 2011; 6(5):e19494. PubMed ID: 21603658
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in inflammation pathway genes and endometrial cancer risk.
Delahanty RJ; Xiang YB; Spurdle A; Beeghly-Fadiel A; Long J; Thompson D; Tomlinson I; Yu H; Lambrechts D; Dörk T; Goodman MT; Zheng Y; Salvesen HB; Bao PP; Amant F; Beckmann MW; Coenegrachts L; Coosemans A; Dubrowinskaja N; Dunning A; Runnebaum IB; Easton D; Ekici AB; Fasching PA; Halle MK; Hein A; Howarth K; Gorman M; Kaydarova D; Krakstad C; Lose F; Lu L; Lurie G; O'Mara T; Matsuno RK; Pharoah P; Risch H; Corssen M; Trovik J; Turmanov N; Wen W; Lu W; Cai Q; Zheng W; Shu XO
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):216-23. PubMed ID: 23221126
[TBL] [Abstract][Full Text] [Related]
15. Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.
Winchester DA; Gurel B; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Thompson IM; Xu J; Zheng SL; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; Drake CG; De Marzo AM; Platz EA
Prostate; 2016 May; 76(6):565-74. PubMed ID: 26771888
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men.
Kopp TI; Friis S; Christensen J; Tjønneland A; Vogel U
Cancer Genet; 2013; 206(7-8):266-78. PubMed ID: 23880210
[TBL] [Abstract][Full Text] [Related]
17. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
Helfand BT; Roehl KA; Cooper PR; McGuire BB; Fitzgerald LM; Cancel-Tassin G; Cornu JN; Bauer S; Van Blarigan EL; Chen X; Duggan D; Ostrander EA; Gwo-Shu M; Zhang ZF; Chang SC; Jeong S; Fontham ET; Smith G; Mohler JL; Berndt SI; McDonnell SK; Kittles R; Rybicki BA; Freedman M; Kantoff PW; Pomerantz M; Breyer JP; Smith JR; Rebbeck TR; Mercola D; Isaacs WB; Wiklund F; Cussenot O; Thibodeau SN; Schaid DJ; Cannon-Albright L; Cooney KA; Chanock SJ; Stanford JL; Chan JM; Witte J; Xu J; Bensen JT; Taylor JA; Catalona WJ
Hum Genet; 2015 Apr; 134(4):439-50. PubMed ID: 25715684
[TBL] [Abstract][Full Text] [Related]
18. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
Salinas CA; Koopmeiners JS; Kwon EM; FitzGerald L; Lin DW; Ostrander EA; Feng Z; Stanford JL
Prostate; 2009 Mar; 69(4):363-72. PubMed ID: 19058137
[TBL] [Abstract][Full Text] [Related]
20. Genetic Polymorphisms in IL-10 Promoter Are Associated With Smoking and Prostate Cancer Risk in African Americans.
Abbas M; Mason T; Ibad A; Khraiwesh M; Apprey V; Kanaan Y; Wilson B; Dunston G; Ricks-Santi L; Brim H
Anticancer Res; 2020 Jan; 40(1):27-34. PubMed ID: 31892550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
